NASDAQ : PAVM

PAVmed Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 1.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.78M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

PAVmed Inc. (PAVM) reported revenue of 112.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue112.00K71.00K3.00M2.45M377.00K500.00K
Cost of Revenue359.00K218.00K4.84M6.42M3.61M585.00K
Gross Profit-247.00K-147.00K-1.84M-3.97M-3.24M-85.00K
Selling, General & Admin20.09M17.17M36.15M48.53M60.73M34.31M
Research & Development6.37M4.49M5.93M14.28M25.34M19.85M
Amortization of Goodwill & Intangibles559.00K2.02M1.78M146.00K
Operating Expenses26.46M21.66M42.64M64.83M87.85M54.31M
Operating Income-26.70M-21.81M-44.49M-68.80M-91.09M-54.39M
Interest Expense-19.00K-21.00K-45.00K-589.00K-1.28M
Interest & Investment Income44.00K29.00K254.00K505.00K169.00K
Other Non Operating Income (Expenses)16.42M14.19M3.96M-7.60M-4.33M1.68M
EBT Excluding Unusual Items-10.26M-7.61M-40.32M-76.48M-96.53M-52.71M
Gain (Loss) on Sale of Investments-2.50M8.48M532.00K
Gain (Loss) on Sale of Assets72.29M1.00M
Other Unusual Items-3.67M-3.35M-4.07M-3.78M-6.71M-3.42M
Pretax Income-16.43M-2.47M28.43M-79.26M-103.24M-56.13M
Earnings From Continuing Operations-16.43M-2.47M28.43M-79.26M-103.24M-56.13M
Minority Interest in Earnings4.34M2.87M11.36M15.09M14.26M5.78M
Net Income-12.09M401.00K39.79M-64.17M-88.98M-50.35M
Preferred Dividends & Other Adjustments8.54M4.17M7.83M2.10M281.00K283.00K
Net Income to Common-20.63M-3.77M31.97M-66.27M-89.26M-50.63M
Shares Outstanding (Basic)2.37M670.47K322.41K241.05K197.95K172.26K
Shares Outstanding (Diluted)2.37M670.47K2.17M241.05K197.95K172.26K
EPS (Basic)-8.69-5.6399.15-274.92-450.95-293.92
EPS (Diluted)-9.85-5.6314.90-274.92-450.95-293.92
Free Cash Flow-7.78M-5.24M-33.61M-52.28M-72.53M-42.06M
Free Cash Flow Per Share-3.28-7.81-15.46-216.88-366.39-244.17
Gross Margin-220.54%-207.04%-61.60%-161.83%-17.00%
Operating Margin-23,841.96%-30,712.68%-1,485.38%-2,805.67%-24,161.01%-10,878.60%
Profit Margin-18,416.96%-5,315.49%1,067.31%-2,702.69%-23,677.45%-10,126.00%
Free Cash Flow Margin-6,948.21%-7,376.06%-1,122.17%-2,132.06%-19,237.40%-8,412.00%
EBITDA-26.62M-21.70M-43.29M-65.86M-88.63M-54.17M
D&A For EBITDA79.00K105.00K1.20M2.93M2.46M226.00K
EBIT-26.70M-21.81M-44.49M-68.80M-91.09M-54.39M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents3.78M1.54M1.19M19.64M39.74M77.26M
Short-Term Investments286.00K414.00K347.00K2.67M3.00M1.99M
Cash & Short-Term Investments4.07M1.95M1.53M22.31M42.75M79.25M
Receivables16.00K15.00K18.00K61.00K17.00K200.00K
Inventory212.00K239.00K266.00K539.00K261.00K526.00K
Prepaid Expenses346.00K212.00K233.00K848.00K300.00K1.86M
Other Current Assets214.00K139.00K115.00K739.00K599.00K808.00K
Total Current Assets4.86M2.56M2.16M24.50M43.93M82.64M
Property, Plant & Equipment1.81M2.08M2.65M6.05M5.49M1.58M
Long-Term Investments33.49M34.12M25.64M
Other Intangible Assets1.42M3.44M2.03M
Other Long-Term Assets51.00K56.00K208.00K1.15M1.12M725.00K
Total Assets40.21M38.81M30.66M33.12M53.98M86.98M
Accounts Payable1.06M678.00K657.00K1.79M2.70M3.30M
Accrued Expenses2.46M1.72M4.81M5.75M3.69M4.23M
Short-Term Debt11.10M29.10M44.20M33.65M
Current Portion of Leases570.00K573.00K513.00K1.56M1.14M
Other Current Liabilities769.00K362.00K873.00K10.00K25.00K
Total Current Liabilities4.09M14.84M35.45M54.18M41.20M7.56M
Long-Term Debt15.10M
Long-Term Leases1.40M1.68M2.25M2.96M1.85M
Total Liabilities20.91M16.51M37.69M57.14M43.05M7.56M
Common Stock6.00K1.00K1.00K9.00K6.00K86.00K
Additional Paid-In Capital295.70M268.02M249.15M237.60M216.19M198.07M
Retained Earnings-264.50M-258.73M-254.97M-294.43M-228.17M-138.91M
Treasury Stock-408.00K
Total Common Equity31.20M9.29M-5.81M-56.82M-12.38M59.25M
Minority Interest-15.74M-11.67M-4.54M29.81M20.61M17.75M
Shareholders' Equity19.31M22.30M-7.03M-24.02M10.93M79.42M
Total Liabilities & Equity40.21M38.81M30.66M33.12M53.98M86.98M
Total Debt17.07M13.35M31.86M48.73M36.64M
Net Cash (Debt)-13.00M-11.40M-30.33M-26.41M6.11M79.25M
Net Cash Per Share-5.48-17.00-13.95-109.5830.88460.05
Filing Date Shares Outstanding6.99M6.32M559.57K305.74K218.71K194.82K
Total Common Shares Outstanding6.27M927.93K373.30K285.95K210.02K191.93K
Working Capital770.00K-12.28M-33.28M-29.68M2.73M75.08M
Book Value Per Share4.9810.01-15.57-198.72-58.93308.69
Tangible Book Value31.20M9.29M-5.81M-58.25M-15.82M57.22M
Tangible Book Value Per Share4.9810.01-15.57-203.70-75.33298.12
Machinery1.43M1.40M3.48M3.23M1.68M
Construction In Progress2.00K2.00K16.00K30.00K38.00K
Leasehold Improvements1.00K1.00K2.00K2.00K2.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-12.09M401.00K39.79M-64.17M-88.98M-50.35M
Depreciation & Amortization79.00K105.00K1.20M2.93M2.46M226.00K
Loss (Gain) From Sale of Assets-72.29M-1.00M
Asset Writedown & Restructuring Costs133.00K
Loss (Gain) From Sale of Investments2.50M-8.48M-532.00K
Stock-Based Compensation4.07M2.21M7.05M11.76M19.53M15.01M
Other Operating Activities-2.58M461.00K-9.28M-3.15M-3.27M-4.05M
Change in Accounts Receivable-13.00K3.00K43.00K-44.00K183.00K-200.00K
Change in Accounts Payable670.00K24.00K-59.00K-918.00K-742.00K174.00K
Change in Other Net Operating Assets-364.00K71.00K528.00K2.55M-157.00K-1.54M
Operating Cash Flow-7.73M-5.21M-33.55M-52.04M-70.98M-40.59M
Capital Expenditures-52.00K-31.00K-55.00K-242.00K-1.54M-1.47M
Sale of Property, Plant & Equipment1.00M
Divestitures-16.48M
Sale (Purchase) of Intangibles350.00K-3.20M-2.25M
Investing Cash Flow-52.00K-31.00K-16.18M758.00K-4.74M-3.72M
Long-Term Debt Issued10.00M35.23M
Total Debt Issued15.00M10.00M35.23M
Long-Term Debt Repaid-531.00K-79.00K-14.97M
Net Debt Issued (Repaid)3.85M-531.00K9.92M35.23M-14.97M
Issuance of Common Stock3.21M1.66M1.79M739.00K126.26M
Repurchase of Common Stock-366.00K
Other Financing Activities-2.00K2.38M30.16M19.46M2.61M-6.98M
Financing Cash Flow7.56M5.59M31.28M31.17M38.21M104.31M
Net Cash Flow-220.00K353.00K-18.45M-20.11M-37.51M60.00M
Free Cash Flow-7.78M-5.24M-33.61M-52.28M-72.53M-42.06M
Free Cash Flow Margin-6,948.21%-7,376.06%-1,122.17%-2,132.06%-19,237.40%-8,412.00%
Free Cash Flow Per Share-3.28-7.81-15.46-216.88-366.39-244.17
Levered Free Cash Flow-11.93M-14.00M-20.32M-27.92M-39.42M-22.18M
Unlevered Free Cash Flow-11.92M-13.98M-20.29M-27.55M-38.62M-22.18M
Change in Working Capital293.00K98.00K512.00K1.59M-716.00K-1.57M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization13.36M6.10M6.95M33.17M44.98M216.32M
Enterprise Value26.35M29.35M39.34M82.43M44.97M181.69M
Last Close Price1.956.6218.83106.53186.18954.15
PE Ratio0.22
PS Ratio121.7585.952.3213.53119.31432.64
PB Ratio0.390.27-0.99-1.384.112.72
P/TBV Ratio0.440.663.78
EV/Sales Ratio237.80413.4013.1433.62119.28363.39
Debt / Equity Ratio0.880.60-4.53-2.033.35
Net Debt / Equity Ratio0.670.51-4.31-1.10-0.56-1.00
Net Debt / EBITDA Ratio-0.49-0.53-0.70-0.400.071.46
Net Debt / FCF Ratio-1.67-2.18-0.90-0.510.081.88
Asset Turnover0.000.000.090.060.010.01
Inventory Turnover1.520.8612.0316.059.180.85
Quick Ratio1.000.130.040.411.0410.51
Current Ratio1.190.170.060.451.0710.93
Return on Equity (ROE)-64.78%-32.34%-228.52%-142.19%
Return on Assets (ROA)-39.69%-39.23%-87.19%-98.73%-80.78%-63.69%
Return on Capital Employed (ROCE)-73.90%-91.00%929.50%326.70%-712.70%-68.50%
Earnings Yield-515.83%6.57%572.90%-193.48%-197.84%-23.28%
FCF Yield-57.07%-85.82%-483.89%-157.61%-161.25%-19.44%
Buyback Yield / Dilution18.99%69.15%-801.63%-21.78%-14.91%-63.42%